AAS
COLL icon

Avantax Advisory Services’s Collegium Pharmaceutical COLL Stock Holding History

Avantax Advisory Services’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-5,617
Closed -$217K – 2197
2024
Q3 		$217K Sell
5,617
-796
-12% -$28.4K ﹤0.01% 1962
2024
Q2 		$206K Buy
+6,413
New +$222K ﹤0.01% 1933

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Avantax Advisory Services's COLL Position: Q4 2024 in Review

Avantax Advisory Services sold out of Collegium Pharmaceutical (COLL) in Q4 2024, closing a stake of 5,617 shares — an estimated $217K sold.

Avantax Advisory Services first reported a position in COLL in Q2 2024 and held it in 2 quarters. The position peaked at $217K in Q3 2024. 238 funds tracked by Wall St. Rank hold COLL as of Q4 2024.

  • Avantax Advisory Services reported no remaining Collegium Pharmaceutical position as of Q4 2024 after selling out during the quarter.
  • Avantax Advisory Services sold 5,617 Collegium Pharmaceutical shares in Q4 2024, an estimated $217K.
  • Avantax Advisory Services first reported a position in Collegium Pharmaceutical in Q2 2024 and held it in 2 quarters.
  • Avantax Advisory Services's Collegium Pharmaceutical position peaked at $217K in Q3 2024.
  • 238 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q4 2024.

Based on Avantax Advisory Services's 13F filing for Q4 2024, filed 10 Feb 2025.